Detection Rate and Clinical Impact of PET/CT with

18F-FACBC 18F-fluciclovine PET/CT biochemical recurrence oncology precision medicine prostate cancer

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
15 Jan 2022
Historique:
received: 21 12 2021
revised: 11 01 2022
accepted: 13 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

Our aim was to assess the detection rate (DR) of positron emission computed tomography (PET/CT) with anti-1-amino-3-[

Identifiants

pubmed: 35052856
pii: biomedicines10010177
doi: 10.3390/biomedicines10010177
pmc: PMC8773479
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63
pubmed: 20848281
J Nucl Med. 2021 Aug 1;62(8):1089-1096
pubmed: 33517323
J Urol. 2017 Mar;197(3 Pt 1):676-683
pubmed: 27746282
J Urol. 2019 Feb;201(2):322-331
pubmed: 30179618
Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775
pubmed: 27900519
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):579-591
pubmed: 31822959
Urol Oncol. 2020 Jul;38(7):636.e1-636.e6
pubmed: 32317221
Expert Rev Med Devices. 2021 Nov;18(11):1107-1110
pubmed: 34608848
J Urol. 2019 Apr;201(4):682-692
pubmed: 30077557
Eur Radiol. 2021 Oct;31(10):8030-8039
pubmed: 33856522
AJR Am J Roentgenol. 2020 Aug;215(2):267-276
pubmed: 32551903
Front Oncol. 2021 Jan 25;10:622501
pubmed: 33569348
Am J Nucl Med Mol Imaging. 2021 Oct 15;11(5):406-414
pubmed: 34754611
Cancers (Basel). 2019 Sep 11;11(9):
pubmed: 31514479
Expert Rev Med Devices. 2019 May;16(5):341-350
pubmed: 30990129
Front Oncol. 2021 Jun 17;11:684629
pubmed: 34222008
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74
pubmed: 16798415
AJR Am J Roentgenol. 2020 Oct;215(4):997-1001
pubmed: 32569513
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):944-945
pubmed: 34239047
J Nucl Med. 2020 Dec;61(12):1793-1799
pubmed: 32358094
Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):316-324
pubmed: 32068113
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Eur Urol. 2021 Apr;79(4):537-544
pubmed: 33317857
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar - Apr;37(2):130-138
pubmed: 28941866
J Nucl Med. 2021 Sep 1;62(9):1252-1257
pubmed: 33547214
Chirality. 2022 Jan;34(1):86-103
pubmed: 34713503
J Clin Oncol. 2006 Aug 20;24(24):3973-8
pubmed: 16921049
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4463-4471
pubmed: 34091713
Int Braz J Urol. 2018 Jan-Feb;44(1):14-21
pubmed: 29039897
Diagnostics (Basel). 2021 Feb 13;11(2):
pubmed: 33668673

Auteurs

Luca Filippi (L)

Nuclear Medicine Unit, "Santa Maria Goretti" Hospital, Via Antonio Canova, 04100 Latina, Italy.

Oreste Bagni (O)

Nuclear Medicine Unit, "Santa Maria Goretti" Hospital, Via Antonio Canova, 04100 Latina, Italy.

Carmelo Crisafulli (C)

Nuclear Medicine Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Cattinara Hospital, Strada di Fiume 447, 34129 Trieste, Italy.

Ivan Cerio (I)

Nuclear Medicine Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Cattinara Hospital, Strada di Fiume 447, 34129 Trieste, Italy.

Gabriele Brunotti (G)

Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Viale Regina Elena 324, 00100 Rome, Italy.

Agostino Chiaravalloti (A)

Department of Biomedicine and Prevention, University Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
IRCCS Neuromed, 86077 Pozzilli, Italy.

Orazio Schillaci (O)

Department of Biomedicine and Prevention, University Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
IRCCS Neuromed, 86077 Pozzilli, Italy.

Franca Dore (F)

Nuclear Medicine Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Cattinara Hospital, Strada di Fiume 447, 34129 Trieste, Italy.

Classifications MeSH